patient-engagement
(17)
Ben Texter
From an electric-car startup to Blue State Digital to a decade building Digital Health Strategies, Ben Texter has made a career of turning complicated systems into clearer human journeys.
Jack Gierlich
Jack Gierlich is a Brooklyn-based growth marketing founder and fractional CMO who has spent 15+ years scaling healthcare, SaaS, and AI companies. He leads marketing and growth at Leal Health (formerly TrialJectory), an AI-powered platform that helps cancer patients find advanced treatment options, and he moderates several of the largest marketing and business communities on Reddit, reaching millions of readers a month. He describes his craft as building marketing systems that compound rather than one-off campaigns.
Matthew Loper
Matthew Loper is the co-founder and CEO of Wellth, a Los Angeles digital-health company that pays people small cash rewards for sticking to their care plans. A biological engineer from MIT turned healthcare banker and investor, he built Wellth around behavioral economics rather than technology - the idea that immediate, tangible incentives change what people actually do about their chronic conditions. Under his leadership Wellth has raised more than $73 million, including an oversubscribed $36 million Series C in 2025, and reports steep drops in hospital and emergency-room use among the high-need Medicare and Medicaid populations it serves.
Lisa Fitzpatrick
Lisa Fitzpatrick is an infectious-disease physician, medical epidemiologist, and founder and CEO of Grapevine Health, a Washington, DC digital health media company that uses street interviews, plain-language video, and text messaging to build trust and health literacy in Black and brown communities. A former CDC Epidemic Intelligence Service officer, Caribbean health diplomat, and chief medical officer for DC Medicaid, she became known as 'Dr. Lisa on the Street' for standing on sidewalks to answer real people's medical questions and bust misinformation.
Dirk Soenksen
Dirk Soenksen is the co-founder and CEO of Ceresti Health, a Carlsbad, California digital-health company that treats the family caregiver as the unit of care for people living with dementia. An engineer by training, he first reshaped a corner of medicine by founding Aperio, the company that turned the glass microscope slide into a digital image and became the global leader in digital pathology before Danaher's Leica Biosystems acquired it in 2012. A coffee on his last day at Leica sent him into a second act: instead of imaging the brain, he set out to support the overwhelmed spouses and adult children caring for it.
Morgan Moncada
Morgan Moncada is the co-founder and CEO of Neru Health, a Boston-based vertical AI company that automates patient support and resupply for durable medical equipment providers and specialty clinics. After more than a decade building life-science startups, he spun Neru out of Harvard's Blavatnik Life Science Fellowship in 2023 with co-founders Maria Grebenshchikova and Catherine Tadina. The company's clinician-trained voice and text assistant, Nora, now supports tens of thousands of patients around the clock - cutting operating costs and lifting therapy compliance for the providers that deploy it.
Ryan Gallagher
Ryan Gallagher is a Stanford- and Harvard-trained physician turned founder who runs Clarion, the AI communication layer for healthcare. After helping build two breakout digital-health companies, Two Chairs and Ophelia, to $100M+ valuations, he started Clarion in 2024 to fix the unglamorous problem that swallows clinics whole: the phone. Clarion's AI agents answer the calls, texts and web chats that overwhelm front desks, handling scheduling, billing, refills and referrals end to end across 84+ EHR systems. Backed by Accel, Y Combinator and Sequoia scouts, the New York company already serves tens of thousands of patients a month.
Samuel Whitaker
Samuel Whitaker is the founder and CEO of Mural Health, a Philadelphia-area clinical trials technology company building a participant-first platform that bundles fee-free payments, transportation, two-way communication, and real-time satisfaction data. He invented the original participant payment tool, the ClinCard, when he founded Greenphire in 2008 and grew it into a billion-dollar company on roughly $2.2 million of outside capital. After a stint as CTO of Signant Health, he launched Mural Health in 2022 to push the same idea further: treating the trial participant, not just the sponsor, as the customer. He also drove the creation of the Harley Jacobsen Act, federal legislation to stop taxing payments to clinical trial participants.
Sebastian Coates
Sebastian Coates is the CEO and co-founder of Tellescope, a HIPAA-compliant, API-first patient communication and CRM platform used by more than 150 digital health organizations. A Tufts computer science and mathematics graduate who once wrote software for the Apple Watch and prototyped blockchain systems for clinical trials at Vertex Pharmaceuticals, he started Tellescope in 2020 with co-founder Derek Strauss to give telehealth companies a developer-friendly tech stack for managing patients across SMS, email, voice, and secure messaging. Notably, he has kept the company lean and profitable rather than chasing oversized venture rounds.
Dave Icke
Dave Icke is the CEO of Medisafe, the medication engagement platform that helps more than ten million patients stay on their treatments. A chemical engineer turned digital-health operator, he has spent two decades turning hardware and software into tools that keep people healthier: founding CEO of wearable biosensor company mc10, launcher of Becton Dickinson's digital health business, VP of Digital Health Product at Humana, and executive chair of mental-health AI company ieso. In 2025 he took the reins at Medisafe from founder Omri Shor to scale medication engagement across the global pharmaceutical ecosystem.
Adnan Iqbal
Adnan Iqbal is the Co-Founder and CEO of Luma Health, a San Mateo-based healthcare technology company that has built an AI-native Patient Success Platform used by 750+ healthcare organizations, 100 million patients, and 500,000+ providers. A second-generation Pakistani-American and serial entrepreneur, Iqbal studied environmental biology at UC Berkeley, earned an MPhil in BioScience from Cambridge University, and an MS/MBA from Stanford GSB. Before Luma, he spent five years in management at Genentech and co-founded AutoTB, a tuberculosis diagnostic startup that won both Cambridge and UC Berkeley entrepreneurship competitions. Luma Health has raised $160 million in funding and enabled $3.2 billion in healthcare revenue.
Josh Rose
Josh Rose is the CEO of Hawthorne Health, Inc. (formerly Hawthorne Effect), a Walnut Creek-based company building the largest community-based clinical trial site network in the U.S. A clinical research industry veteran with over 20 years of experience, Rose previously led decentralized clinical trial strategy at IQVIA and CVS Health before taking the helm at Hawthorne Health in early 2024. Under his leadership, Hawthorne has expanded to 75+ community locations, partnered with 40+ pharma sponsors, and pioneered a model that embeds certified clinical research staff inside independent pharmacies and patients' homes - bringing trials to communities that traditional research networks have long bypassed.
Kim Parikh
Kim Parikh is Co-Founder and SVP of Data and Content at Hippocratic AI, a Palo Alto-based company building the first safety-focused large language model for healthcare. With a background spanning leveraged finance at PIMCO and Western Asset Management and strategy operations at Health IQ, Parikh brings a cross-disciplinary lens to one of AI's most consequential bets: putting voice-enabled AI agents into direct, empathetic contact with patients. Hippocratic AI has raised over $438M, most recently a $126M Series C in November 2025, and has completed over 1.8 million patient calls at a 8.95/10 satisfaction rating.
Michelle Longmire
Dr. Michelle Longmire is the co-founder and CEO of Medable, the leading platform for agentic AI in clinical development. A Stanford-trained physician-scientist who grew up in a Los Alamos nuclear-research family, she pivoted from dermatology to founding Medable in 2015 after hitting enrollment walls in her own clinical research. Under her leadership, Medable has raised over $500 million in venture capital, deployed its platform in roughly 400 trials across 70 countries in 120 languages, and served more than one million patients globally - transforming how the world runs clinical trials.
Pranay Kapadia
Pranay Kapadia is the Co-Founder and CEO of Notable, an AI-powered automation platform for healthcare that eliminates administrative burden for clinicians and health systems. Founded in 2017 after dinner-table conversations with six physician family members - including his psychiatrist wife who called herself 'the highest paid data collector in the world' - Notable has grown to serve 32 million patients across 12,000 sites of care, raised $119.2M in funding including a $100M Series B in 2021, and now automates over one million repetitive healthcare workflows daily. Before Notable, Kapadia helped build Mint.com at Intuit and was on the founding team at Blend, the mortgage fintech unicorn.
David Craig
David Craig, MD is the CEO of Spruce Health, a San Francisco-based HIPAA-compliant healthcare communication platform serving 25,000+ healthcare providers. A Stanford-trained emergency medicine physician who began coding in his teens, Craig brings rare dual fluency in medicine and software engineering. He joined Spruce in 2014 as Chief Medical Officer before taking the CEO role in late 2021, and still works weekly ER shifts to keep his clinical perspective sharp while leading a team building the communication infrastructure for modern healthcare.
Leslie Wilberforce
Leslie Oley Wilberforce is the CEO of Evidation, a San Mateo-based digital health company that has built a 5-million-person platform where individuals share permissioned health data to power real-world clinical research. A mechanical engineer by training (BS Penn State, MS Stanford), she joined Evidation in 2015 and spent a decade building the company's enterprise technology platform and landmark partnerships with Johnson & Johnson, Apple, the Michael J. Fox Foundation, and the American Heart Association before becoming Evidation's first non-founder CEO in March 2025.